Pharmafile Logo
Pharmafocus logo
Advanced Search

oncology

Showing 15 posts of 294 posts found.

Herceptin image

The new paradigm in oncology drug marketing

October 21, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Herceptin, Roche, marketing, oncology

Twenty years ago drugs to treat cancer were made up of chemotherapy agents which are essentially ‘blunt tools’ against the …

Feature

Boehringer and Ventana link up

September 24, 2013
Research and Development, Sales and Marketing Boehringer, Ventana, oncology

Boehringer Ingelheim has signed a deal with Roche subsidiary Ventana Medical Systems to develop companion diagnostic tests for Boehringer’s oncology …

News
Bayer image

Bayer partners with US academics

September 13, 2013
Research and Development, Sales and Marketing Bayer, Cancer, broad, oncology

Bayer HealthCare and a prestigious US academic institution have signed a five-year deal to find new oncology treatments. The German …

News
claire_thom_astellas

Astellas hires senior VP from rival Takeda

August 15, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Takeda, oncology

Astellas has appointed Claire Thom from fellow Japanese firm Takeda to be senior vice president of its global oncology development. …

Appointment
pfizerworld

Pfizer abandons cancer trial

May 22, 2013
Research and Development, Sales and Marketing Cancer, Inotuzumab ozogamicin, Pfizer, oncology

Pfizer’s oncology pipeline has suffered a blow with the company abandoning a Phase III study of one of its investigational …

News
Roche image

Swiss Re helps Roche open up China’s oncology market

December 17, 2012
Sales and Marketing Cancer, China, Roche, Swiss re, oncology

Roche and reinsurance firm Swiss Re have teamed up to find an innovative way into China’s healthcare market. For the …

News
novartis_window

Novartis blood cancer hope

December 12, 2012
Research and Development, Sales and Marketing Jakavi, Novartis, oncology

Two-year data from Novartis’s drug Jakavi suggests that it may improve overall survival in a rare form of cancer versus …

News
lilly corporate hq image

Lilly suffers late-stage cancer blow

September 10, 2012
Research and Development, Sales and Marketing Alimta, Cancer, avastin, lilly, oncology

Eli Lilly suffered a blow to its oncology programme when a new combination treatment failed to improve overall survival in …

News
merck kgaa image

Merck KGaA licences new cancer candidate

September 10, 2012
Research and Development, Sales and Marketing Cancer, EGFR, Merck KGaA, oncology

Merck KGaA has signed a worldwide licence agreement with Danish company Symphogen which could expand its portfolio of drugs targeting …

News
GSK image

GSK submits melanoma drugs for regulatory approval

August 3, 2012
Sales and Marketing FDA, GSK, NDA, Zelboraf, melanoma, oncology

GlaxoSmithKline has submitted its two investigational melanoma drugs to regulators in both Europe and the US. The firm is seeking …

News

Boehringer collaborates with Havard

July 9, 2012
Research and Development, Sales and Marketing Boehringer, Havard, oncology, research deal

Boehringer Ingelheim has established a translational research collaboration with the presidents and fellows of Harvard College. The aim of the …

News
redfern_celgene

New director of market access at Celgene UK and Ireland

June 18, 2012
Business Services, Medical Communications, Sales and Marketing Celgene, Nicola Redfern, oncology

Celgene has announced the appointment of Nicola Redfern as director of market access, Celgene UK and Ireland. Redfern brings a …

Appointment
Lilly oncology image

Lilly app aims to boost trial recruitment

June 8, 2012
Medical Communications GSK, clinical trials, lilly, oncology

Lilly has launched a new searchable clinical trial mobile app for oncologists. The app is available for the iPad and …

News

Lilly teams up with ImmunoGen on antibody-drug conjugates

December 21, 2011
ADC, Cancer, Immunogen, T-DM1, conjugate, lilly, oncology

ImmunoGen has signed a new collaboration with Eli Lilly to develop antibody-drug conjugate for cancer treatments.Lilly will pay an upfront …

News

New cancer drug costs escalating for NHS

December 13, 2011
Cancer, NHS, oncology

New oncology drugs are pushing up the overall costs of treating cancer, according to a new report. The ‘Cancer Diagnosis …

News

Latest content

FDA grants marketing authorisation to DNA test for predisposition to certain cancers

October 2, 2023

Biogen’s biosimilar Tofidence approved by FDA

October 2, 2023

Austrian state secretary to speak at FlyPharma Europe 2023

September 29, 2023

Karuna Therapeutics submits NDA to FDA for schizophrenia treatment

September 29, 2023

Kura Oncology shares preclinical data for NSCLC treatment

September 29, 2023